Reuters
Search documents
Swiss authorities to analyse court decision on Credit Suisse bond write-off
Reuters· 2025-10-14 12:19
The Swiss government and the country's financial market regulator on Tuesday both said they would analyse a court's partial decision that the write-off of Credit Suisse AT1 debt as part of the bank's ... ...
Meta's Instagram to add PG-13 movie-style rating for teen accounts
Reuters· 2025-10-14 12:16
Meta said on Tuesday that teenager accounts on Instagram will be guided by PG-13 movie ratings by default, as the social media company faces intense scrutiny for not doing enough to protect users unde... ...
LVMH names Maria Grazia Chiuri chief designer at Fendi
Reuters· 2025-10-14 12:07
French luxury group LVMH on Tuesday said it named Maria Grazia Chiuri, the former Dior designer, the new creative director of Italian fashion label Fendi. ...
Citigroup profit climbs on record revenue, while Mexico sale drags
Reuters· 2025-10-14 12:04
Citigroup reported a rise in third-quarter profit, as all its divisions brought in record revenue, sending the bank's shares up about 1% in trading before the bell. ...
BioCryst to buy Astria Therapeutics in $700 million deal
Reuters· 2025-10-14 11:35
Core Viewpoint - BioCryst Pharmaceuticals is acquiring Astria Therapeutics in a cash-and-stock deal valued at approximately $700 million, aiming to enhance its portfolio of treatments for rare diseases [1] Company Summary - The acquisition is part of BioCryst Pharmaceuticals' strategy to expand its offerings in the rare disease treatment market [1] - The deal is structured as a combination of cash and stock, indicating a significant investment in Astria Therapeutics [1] Industry Summary - The move reflects a growing trend in the pharmaceutical industry towards consolidation, particularly in the niche market of rare diseases [1] - This acquisition may position BioCryst Pharmaceuticals more competitively within the rare disease sector, potentially leading to increased market share and innovation in treatment options [1]
Goldman Sachs profit jumps as bankers cash in on big deals
Reuters· 2025-10-14 11:27
Goldman Sachs' quarterly profit jumped more than 37% on Tuesday as its investment bankers earned higher advisory fees and traders capitalized on active markets. ...
Exclusive: Broadcom to launch new networking chip, as battle with Nvidia intensifies
Reuters· 2025-10-14 11:01
Broadcom is launching a new networking chip on Tuesday that will help companies build artificial intelligence computing systems by stringing together hundreds of thousands of chips that crunch data, d... ...
India's Infosys wins $1.6 billion deal from UK's National Health Service
Reuters· 2025-10-14 10:57
India's Infosys said on Tuesday it has won a 1.2 billion pound ($1.59 billion) deal from the UK's National Health Services Business Services Authority. ...
GM takes $1.6 billion charge as it reassesses EV plans
Reuters· 2025-10-14 10:36
Core Viewpoint - General Motors will incur charges totaling $1.6 billion in the third quarter due to a realignment of its electric-vehicle capacity and manufacturing in response to softer demand [1] Group 1 - The company is adjusting its electric-vehicle strategy to better align with current market demand [1] - The $1.6 billion charges reflect the financial impact of these strategic changes [1]
JPMorgan profit rises on investment banking boom, trading strength
Reuters· 2025-10-14 10:34
Core Insights - JPMorgan Chase's profit increased in the third quarter, driven by multi-billion dollar deals and IPOs that enhanced its investment banking segment, alongside improved trading performance [1] Group 1: Financial Performance - The profit rise in the third quarter indicates strong financial health for JPMorgan Chase, attributed to significant contributions from investment banking activities [1] - The performance in trading also showed strength, suggesting a robust operational environment for the bank [1] Group 2: Investment Banking - Multi-billion dollar deals and IPOs were key factors in boosting the investment banking division, highlighting the bank's active role in capital markets [1]